JonathanBenjaminKahnMD(He/Him)

PubMed

• Spontaneous Reattachment of a Detached Sutured Descemet-Stripping Automated Endothelial Keratoplasty Graft.
  Gad, R., Kahn, J., Trief, D.> ;Case Reports in Ophthalmology. 2024 Jan 12
• 43 citations
  Quantification of the Cost and Potential Environmental Effects of Unused Pharmaceutical Products in Cataract Surgery
  Jenna Tauber, Ijeoma Chinwuba, David Kleyn, Michael Rothschild, Jonathan B. Kahn, Cassandra L. Thiel> ;JAMA Ophthalmology. 2019 Oct 1
• 2 citations
  Pills for Prejudice: Implicit Bias and Technical Fix for Racism.
  Jonathan Kahn> ;American Journal of Law & Medicine. 2017 Dec 18
• 3 citations
  Science Is Complex-So Is Race.
  Jonathan Kahn> ;The American Journal of Bioethics. 2017 Aug 22
• 3 citations
  Infarcted Tarsal Pyogenic Granuloma Simulating Malignant Melanoma.
  Norman C. Charles, Jonathan B. Kahn> ;Ophthalmic Plastic and Reconstructive Surgery. 2017 May 1
• 1 citations
  ‘When are you from?’ Time, space, and capital in the molecular reinscription of race
  Jonathan Kahn> ;The British Journal of Sociology. 2015 Mar 1
• 44 citations
  The OHRP and SUPPORT — Another View
  Ruth Macklin, Lois Shepherd, Alice Dreger, Adrienne Asch, Françoise Baylis, Howard Brody, Larry R. Churchill, Carl H. Coleman, Ethan Cowan, Janet L. Dolgin, Jocelyn Do...> ;The New England Journal of Medicine. 2013 Jul 10
• 3 citations
  The troubling persistence of race in pharmacogenomics.
  Jonathan Kahn> ;The Journal of Law, Medicine & Ethics. 2012 Dec 1
• 155 citations
  Topography-guided hyperopic LASIK with and without high irradiance collagen cross-linking: initial comparative clinical findings in a contralateral eye study of 34 con...
  Anastasios John Kanellopoulos, Jonathan Kahn> ;Journal of Refractive Surgery. 2012 Nov 1
• Connecting the dots in translational research.
  Jonathan Kahn> ;Nature Reviews. Drug Discovery. 2012 Sep 24
• 7 citations
  Spectral-domain optical coherence tomography as a screening technique for chloroquine and hydroxychloroquine retinal toxicity.
  Jonathan B. Kahn, Ilyse D. Haberman, Shantan Reddy> ;Ophthalmic Surgery, Lasers & Imaging. 2011 Aug 11
• 6 citations
  Mandating race: how the USPTO is forcing race into biotech patents.
  Jonathan Kahn> ;Nature Biotechnology. 2011 May 6
• 5 citations
  The two (institutional) cultures: a consideration of structural barriers to interdisciplinarity.
  Jonathan Kahn> ;Perspectives in Biology and Medicine. 2011 Jan 1
• 10 citations
  Orbital dissemination of Lemierre syndrome from gram-positive septic emboli.
  Jonathan B. Kahn, Samuel Baharestani, Heather C. Beck, Diana Ng, Christopher I. Zoumalan, Floyd A. Warren, Richard N. Palu> ;Ophthalmic Plastic and Reconstructive Surgery. 2010 Oct 1
• 81 citations
  Race and ancestry in biomedical research: exploring the challenges
  Timothy Caulfield, Stephanie M. Fullerton, Sarah E. Ali-Khan, Laura Arbour, Esteban G. Burchard, Richard S. Cooper, Billie Jo Hardy, Simrat Harry, Robyn Hyde-Lay, Jona...> ;Genome Medicine. 2009 Jan 21
• 4 citations
  Race, Genes, and Justice: A Call to Reform the Presentation of Forensic DNA Evidence in Criminal Trials.
  Jonathan Kahn> ;Brooklyn Law Review. 2008 Dec 1
• 9 citations
  Exploiting race in drug development: BiDil's interim model of pharmacogenomics.
  Jonathan Kahn> ;Social Studies of Science. 2008 Oct 1
• 10 citations
  Flaws in the U.S. Food and Drug Administration's Rationale for Supporting the Development and Approval of BiDil as a Treatment for Heart Failure Only in Black Patients:
  George T. H. Ellison, Jay S. Kaufman, Rosemary F. Head, Paul Martin, Jonathan Kahn> ;The Journal of Law, Medicine & Ethics. 2008 Sep 1
• 84 citations
  The Science and Business of Genetic Ancestry Testing
  Deborah A. Bolnick, Duana Fullwiley, Troy Duster, Richard S. Cooper, Joan H. Fujimura, Jonathan Kahn, Jay S. Kaufman, Jonathan Marks, Ann Morning, Alondra Nelson, Pila...> ;Science. 2007 Oct 19
• 6 citations
  Race in a bottle. Drugmakers are eager to develop medicines targeted at ethnic groups, but so far they have made poor choices based on unsound science.
  Jonathan Kahn> ;Scientific American. 2007 Aug 1
• 17 citations
  Race, pharmacogenomics, and marketing: putting BiDil in context.
  Jonathan Kahn> ;The American Journal of Bioethics. 2006 Nov 23
• 28 citations
  Genes, Race, and Population: Avoiding a Collision of Categories
  Jonathan Kahn> ;American Journal of Public Health. 2006 Oct 3
• 5 citations
  Being specific about race-specific medicine.
  Jonathan Kahn, Pamela Sankar> ;Health Affairs. 2006 Sep 1
• 1 citations
  BiDil: false promises: faulty statistics and reasoning have lead to the first "racial medicine".
  Jonathan Kahn> ;Genewatch. 2005 Nov 1
• 35 citations
  BiDil: Race Medicine Or Race Marketing?
  Pamela Sankar, Jonathan Kahn> ;Health Affairs. 2005 Oct 11
• Join now to see all